Home › NCT07243652

I-DECIDE After Bronchiolitis Hospitalization

Cluster Randomized Trial of a Moderate vs High Resource Implementation Strategy to Increase As-needed Post-hospitalization Follow-up for Children With Bronchiolitis

Who can join

0 Months – 24 Months · All sexes

Inclusion Criteria:

* Primary diagnosis of bronchiolitis, discharged by a generalist inpatient service from a non-ICU, non-emergency department, non-step down unit

Exclusion Criteria:

* Children with a history of gestational age \<28 weeks, chronic lung disease, complex or hemodynamically significant heart disease, immunodeficiency, or neuromuscular disease
* Children being discharged with home oxygen therapy

About the study

Although automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis. Despite endorsement by national pediatric authorities, robust evidence, and family enthusiasm for as-needed (PRN) follow-up, it remains substantially underutilized for children hospitalized for bronchiolitis.

The goal of I-DECIDE is to compare the effects of two multi-component implementation strategies, both of which aim to (a) increase PRN follow-up prescribing by hospitalists (physicians who care for hospitalized children) and (b) decrease unnecessary follow-up visit attendance by families.

What is being tested

• Moderate-Resource Implementation Strategy (other)
• High-Resource Implementation Strategy (other)

Sponsor: Seattle Children's Hospital · Participants: 2,700 · Started: Nov 1, 2025

Contact the study team

• Eric Coon, MD, MS · Phone: 206-884-1223

Official record on ClinicalTrials.gov — NCT07243652

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.